Targeting of inflammatory pathways with R2CHOP in high-risk DLBCL
Hartert, Keenan T., Wenzl, Kerstin, Krull, Jordan E., Manske, Michelle, Sarangi, Vivekananda, Asmann, Yan, Larson, Melissa C., Maurer, Matthew J., Slager, Susan, Macon, William R., King, Rebecca L., Feldman, Andrew L., Gandhi, Anita K., Link, Brian K., Habermann, Thomas M., Yang, Zhi-Zhang, Ansell, Stephen M., Cerhan, James R., Witzig, Thomas E., Nowakowski, Grzegorz S., Novak, Anne J.
Published in Leukemia (01.02.2021)
Published in Leukemia (01.02.2021)
Get full text
Journal Article
FAM171B is a novel polyglutamine protein widely expressed in the mammalian brain
Tran, Quan, Sudasinghe, Ashani, Jones, Brooke, Xiong, Ka, Cohen, Rachel E., Sharlin, David S., Hartert, Keenan T., Goellner, Geoffrey M.
Published in Brain research (01.09.2021)
Published in Brain research (01.09.2021)
Get full text
Journal Article
Integrative analyses reveal outcome-associated and targetable molecular partnerships between TP53, BRD4, TNFRSF10B, and CDKN1A in diffuse large B-cell lymphoma
Forberg, Aidan L., Unrau, Jordan, Weber, Kennedee S., Rutz, Alison C., Lund, Shelby, Guidinger, Jinda, Pelzel, Andrew, Hauge, Jackson, Hemmen, Ainslee J., Hartert, Keenan T.
Published in Annals of hematology (2024)
Published in Annals of hematology (2024)
Get full text
Journal Article
Somatic copy number gains in MYC, BCL2, and BCL6 identifies a subset of aggressive alternative-DH/TH DLBCL patients
Krull, Jordan E., Wenzl, Kerstin, Hartert, Keenan T., Manske, Michelle K., Sarangi, Vivekananda, Maurer, Matthew J., Larson, Melissa C., Nowakowski, Grzegorz S., Ansell, Stephen M., McPhail, Ellen, Habermann, Thomas M., Link, Brian K., King, Rebecca L., Cerhan, James R., Novak, Anne J.
Published in Blood cancer journal (New York) (09.11.2020)
Published in Blood cancer journal (New York) (09.11.2020)
Get full text
Journal Article
Molecular classification and identification of an aggressive signature in low-grade B-cell lymphomas
Hopper, Melissa A, Wenzl, Kerstin, Hartert, Keenan T, Krull, Jordan E, Dropik, Abigail R, Novak, Joseph P, Manske, Michelle K, Serres, MaKayla R, Sarangi, Vivekananda, Larson, Melissa C, Maurer, Matthew J, Yang, Zhi-Zhang, Paludo, Jonas, McPhail, Ellen D, Habermann, Thomas M, Link, Brian K, Rimsza, Lisa M, Ansell, Stephen M, Cerhan, James R, Jevremovic, Dragan, Novak, Anne J
Published in Hematological oncology (01.10.2023)
Published in Hematological oncology (01.10.2023)
Get full text
Journal Article
EFS24 Failure, BRD4 Expression, and TP53 Are Linked to Reduced CDKN1A Expression in DLBCL and May be Targeted By Single-Agent Protac ARV-825 or in Synergistic Combination with the CDK4/6 Inhibitor Abemaciclib
Rutz, Alison, Weber, Kennedee, Lund, Shelby, Guidinger, Jinda, Forberg, Aidan, Hartert, Keenan T.
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
The DLBCL Axis of Low TNFRSF10B Expression, TP53 Loss, and a Cold Immune Microenvironment May be Addressed By the Synergistic Combination of Eprenetapopt and Idasnutlin
Rutz, Alison, Lund, Shelby, Guidinger, Jinda, Weber, Kennedee, Forberg, Aidan, Hartert, Keenan T.
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
Cooperative Networks between MYC and XPO1 Associated with Decreased T-Cell Presence and a Depleted Tumor Microenvironment May be Addressed By the Synergistic Combination of AZD4573 and Selinexor
Weber, Kennedee, Forberg, Aidan, Unrau, Jordan, Rutz, Alison, Lund, Shelby, Hauge, Jackson, Hemmen, Ainslee, Hartert, Keenan T
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Integration of Tumor Transcriptomic, Genomic, and Immune Profiles Reveals Distinct Populations of Low-Grade B-Cell Lymphomas with Poor Outcome
Hopper, Melissa A., Wenzl, Kerstin, Hartert, Keenan T., Krull, Jordan E., Novak, Joseph P., Manske, Michelle K., Serres, MaKayla R., Sarangi, Vivekananda, Larson, Melissa C., Maurer, Matthew J., Paludo, Jonas, McPhail, Ellen D., Habermann, Thomas M., Link, Brian K., Rimsza, Lisa M., Ansell, Stephen M., Cerhan, James R., Jevremovic, Dragan, Novak, Anne J.
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article
Integration of Genetic, Transcriptomic, and Immune Profiles Reveals Genomically-Distinct Populations in Low-Grade Lymphomas
Hartert, Keenan T., Wenzl, Kerstin, Krull, Jordan, Manske, Michelle, Sarangi, Vivekananda, Larson, Melissa C, Anagnostou, Theodora, McPhail, Ellen D., Link, Brian K., Ansell, Stephen M, Cerhan, James R., Jevremovic, Dragan, Novak, Anne J
Published in Blood (13.11.2019)
Published in Blood (13.11.2019)
Get full text
Journal Article
Genomic Analysis of R2CHOP-Treated DLBCL Reveals a High-Risk Population Driven By Inflammatory Pathways
Hartert, Keenan T., Wenzl, Kerstin, Krull, Jordan, Manske, Michelle, Sarangi, Vivekananda, Asmann, Yan, Larson, Melissa C, Maurer, Matthew J, Slager, Susan L., Macon, William R., King, Rebecca L., Feldman, Andrew L., Gandhi, Anita K, Link, Brian K., Habermann, Thomas M., Yang, Zhi-Zhang, Ansell, Stephen M, Cerhan, James R., Witzig, Thomas E., Nowakowski, Grzegorz, Novak, Anne J
Published in Blood (13.11.2019)
Published in Blood (13.11.2019)
Get full text
Journal Article
Enrichment of TP53 alterations within GCB-like DNA subclassifications of diffuse large B-cell lymphoma after transition from de-novo to relapsed or refractory disease
Lund, Shelby, Ngisa, Valentine, Weber, Kennedee, Rutz, Alison, Guidinger, Jinda, Hartert, Keenan T
Published in Blood research (30.06.2022)
Published in Blood research (30.06.2022)
Get full text
Journal Article